| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.48 | 0.0009 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |